Scienture Holdings (SCNX) Retained Earnings (2013 - 2026)
Scienture Holdings' (SCNX) quarterly Retained Earnings came in at $150.9 million in Q2 2026, up 19.1% year-over-year from $126.7 million in Q2 2025, and little changed quarter-over-quarter from $150.8 million in Q1 2026.
Analysis
Scienture Holdings (SCNX) Retained Earnings (2013 - 2026) Analysis & Trends
Scienture Holdings has disclosed Retained Earnings across 14 years of filings, most recently posting $150.9 million for Q2 2026.
- In Q2 2026, Retained Earnings rose 19.1% year-over-year to $150.9 million; the TTM figure through Jun 2026 stood at $150.9 million (up 19.1% YoY), while the FY2025 annual figure was $150.7 million, up 27.57% from the prior year.
- Retained Earnings came in at $150.9 million for Q2 2026 at Scienture Holdings, roughly flat from $150.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $150.9 million in Q2 2026 to a low of -$21.9 million in Q2 2023.
- Average Retained Earnings over 5 years is $68.2 million, with a median of $38.3 million recorded in 2024.
- Year-over-year, Retained Earnings tumbled 208.89% in 2023 and soared 274.84% in 2024.
- Over 5 years, Retained Earnings stood at $20.5 million in 2022, then soared by 64.96% to $33.8 million in 2023, then surged by 249.56% to $118.1 million in 2024, then advanced by 27.57% to $150.7 million in 2025, then advanced by 0.14% to $150.9 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $150.9 million in Q2 2026, $150.8 million in Q1 2026, and $150.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 28.26 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 18.56 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 3.76 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 545.58 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | -10.83 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 620.25 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -2.48 Bn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 703.65 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | -227.25 Mn |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | 150.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 150.88 Mn |
| Mar 31, 2026 | 150.77 Mn |
| Dec 31, 2025 | 150.67 Mn |
| Jun 30, 2025 | 126.68 Mn |
| Mar 31, 2025 | 123.27 Mn |
| Dec 31, 2024 | 118.11 Mn |
| Jun 30, 2024 | 38.29 Mn |
| Mar 31, 2024 | 38.29 Mn |
| Dec 31, 2023 | 33.79 Mn |
| Sep 30, 2023 | 33.09 Mn |
| Jun 30, 2023 | -21.90 Mn |
| Dec 31, 2022 | 20.48 Mn |
| Sep 30, 2022 | 20.19 Mn |
| Jun 30, 2022 | 20.11 Mn |
| Mar 31, 2022 | 20.08 Mn |
| Dec 31, 2021 | 20.02 Mn |
| Sep 30, 2021 | 20.08 Mn |
| Jun 30, 2021 | 19.95 Mn |
| Mar 31, 2021 | 19.78 Mn |
| Dec 31, 2020 | 19.61 Mn |